Skip to main content
Top
Published in: Critical Care 5/2013

Open Access 01-10-2013 | Research

The impact of crystalloidal and colloidal infusion preparations on coronary vascular integrity, interstitial oedema and cardiac performance in isolated hearts

Authors: York A Zausig, Daniel Chappell, Bernhard F Becker, Daniel Potschka, Hendrik Busse, Kathrin Nixdorf, Diane Bitzinger, Barbara Jacob, Matthias Jacob

Published in: Critical Care | Issue 5/2013

Login to get access

Abstract

Introduction

Recent data suggested an interaction between plasma constituents and the endothelial glycocalyx to be relevant for vascular barrier function. This might be negatively influenced by infusion solutions, depending on ionic composition, pH and binding properties. The present study evaluated such an influence of current artificial preparations.

Methods

Isolated guinea pig hearts were prepared in a modified Langendorff mode and perfused with Krebs-Henseleit buffer augmented with 1g% human albumin. After equilibration the perfusion was switched to replacement of one half buffer by either isotonic saline (NaCl), ringer's acetate (Ri-Ac), 6% and 10% hydroxyethyl starch (6% and 10% HES, resp.), or 4% gelatine (Gel), the artificial colloids having been prepared in balanced solution. We analysed glycocalyx shedding, functional integrity of the vascular barrier and heart performance.

Results

While glycocalyx shedding was not observed, diluting albumin concentration towards 0.5g% by artificial solutions was associated with a marked functional breakdown of vascular barrier competence. This effect was biggest with isotonic saline and significantly attenuated with artificial colloids, the difference in the pressure dependent transvascular fluid filtration (basal vs. during infusion in groups NaCl, Ri-Ac, 6% HES, 10% HES and Gel, n = 6 each) being 0.31 ± 0.03 vs. 1.00 ± 0.04; 0.27 ± 0.03 vs. 0.81 ± 0.03; 0.29 ± 0.03 vs. 0.68 ± 0.02; 0.32 ± 0.03 vs. 0.59 ± 0.08 and 0.31 ± 0.04 vs. 0.61 ± 0.03 g/5min, respectively. Heart performance was directly related to pH value (7.38 ± 0.06, 7.33 ± 0.03, 7.14 ± 0.04, 7.08 ± 0.04, 7.25 ± 0.03), the change in the rate pressure product being 21,702 ± 1969 vs. 21,291 ± 2,552; 22,098 ± 2,115 vs. 14,114 ± 3,386; 20,897 ± 2,083 vs. 10,671 ± 1,948; 21,822 ± 2,470 vs. 10,047 ± 2,320 and 20,955 ± 2,296 vs. 15,951 ± 2,755 mmHg × bpm, respectively.

Conclusions

It appears important to maintain the pH value within a physiological range to maintain optimal myocardial contractility. Using colloids prepared in calcium-containing, balanced solutions for volume replacement therapy may attenuate the breakdown of vascular barrier competence in the critically ill.
Appendix
Available only for authorised users
Literature
1.
go back to reference Starling E: On the absorption of fluid from the connective tissue spaces. J Physiol (Lond) 1896, 19: 312-326.CrossRef Starling E: On the absorption of fluid from the connective tissue spaces. J Physiol (Lond) 1896, 19: 312-326.CrossRef
2.
go back to reference Adamson RH, Lenz JF, Zhang X, Adamson GN, Weinbaum S, Curry FE: Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 2004, 557: 889-907. 10.1113/jphysiol.2003.058255PubMedCentralCrossRefPubMed Adamson RH, Lenz JF, Zhang X, Adamson GN, Weinbaum S, Curry FE: Oncotic pressures opposing filtration across non-fenestrated rat microvessels. J Physiol 2004, 557: 889-907. 10.1113/jphysiol.2003.058255PubMedCentralCrossRefPubMed
3.
go back to reference Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, Jacob M, Becker BF: Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004, 100: 1211-1223. 10.1097/00000542-200405000-00025CrossRefPubMed Rehm M, Zahler S, Lotsch M, Welsch U, Conzen P, Jacob M, Becker BF: Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004, 100: 1211-1223. 10.1097/00000542-200405000-00025CrossRefPubMed
4.
go back to reference Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007, 73: 575-586. 10.1016/j.cardiores.2006.11.021CrossRefPubMed Jacob M, Bruegger D, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: The endothelial glycocalyx affords compatibility of Starling's principle and high cardiac interstitial albumin levels. Cardiovasc Res 2007, 73: 575-586. 10.1016/j.cardiores.2006.11.021CrossRefPubMed
5.
go back to reference Becker BF, Chappell D, Jacob M: Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol 2010, 105: 687-701.CrossRefPubMed Becker BF, Chappell D, Jacob M: Endothelial glycocalyx and coronary vascular permeability: the fringe benefit. Basic Res Cardiol 2010, 105: 687-701.CrossRefPubMed
6.
go back to reference Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M: Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010, 87: 300-310. 10.1093/cvr/cvq137CrossRefPubMed Becker BF, Chappell D, Bruegger D, Annecke T, Jacob M: Therapeutic strategies targeting the endothelial glycocalyx: acute deficits, but great potential. Cardiovasc Res 2010, 87: 300-310. 10.1093/cvr/cvq137CrossRefPubMed
7.
go back to reference Weinbaum S, Tarbell JM, Damiano ER: The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007, 9: 121-167. 10.1146/annurev.bioeng.9.060906.151959CrossRefPubMed Weinbaum S, Tarbell JM, Damiano ER: The structure and function of the endothelial glycocalyx layer. Annu Rev Biomed Eng 2007, 9: 121-167. 10.1146/annurev.bioeng.9.060906.151959CrossRefPubMed
8.
go back to reference Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF: Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006, 104: 1223-1231. 10.1097/00000542-200606000-00018CrossRefPubMed Jacob M, Bruegger D, Rehm M, Welsch U, Conzen P, Becker BF: Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006, 104: 1223-1231. 10.1097/00000542-200606000-00018CrossRefPubMed
9.
go back to reference Chappell D, Jacob M, Hofmann-Kiefer K, Rehm M, Welsch U, Conzen P, Becker BF: Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc Res 2009, 83: 388-396. 10.1093/cvr/cvp097CrossRefPubMed Chappell D, Jacob M, Hofmann-Kiefer K, Rehm M, Welsch U, Conzen P, Becker BF: Antithrombin reduces shedding of the endothelial glycocalyx following ischaemia/reperfusion. Cardiovasc Res 2009, 83: 388-396. 10.1093/cvr/cvp097CrossRefPubMed
10.
go back to reference Chappell D, Doerfler N, Jacob M, Rehm M, Welsch U, Conzen P, Becker BF: Glycocalyx protection reduces leukocyte adhesion following ischemia/reperfusion. Shock 2010, 34: 133-139. 10.1097/SHK.0b013e3181cdc363CrossRefPubMed Chappell D, Doerfler N, Jacob M, Rehm M, Welsch U, Conzen P, Becker BF: Glycocalyx protection reduces leukocyte adhesion following ischemia/reperfusion. Shock 2010, 34: 133-139. 10.1097/SHK.0b013e3181cdc363CrossRefPubMed
11.
go back to reference Jacob M, Paul O, Mehringer L, Chappell D, Rehm M, Welsch U, Kaczmarek I, Conzen P, Becker BF: Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 2009, 87: 956-965. 10.1097/TP.0b013e31819c83b5CrossRefPubMed Jacob M, Paul O, Mehringer L, Chappell D, Rehm M, Welsch U, Kaczmarek I, Conzen P, Becker BF: Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia. Transplantation 2009, 87: 956-965. 10.1097/TP.0b013e31819c83b5CrossRefPubMed
12.
go back to reference Zahler S, Kupatt C, Seligmann C, Kowalski C, Becker BF, Gerlach E: Retention of leucocytes in reperfused, isolated hearts does not cause haemodynamically relevant permanent capillary plugging. Pflugers Arch 1997, 433: 713-720. 10.1007/s004240050336CrossRefPubMed Zahler S, Kupatt C, Seligmann C, Kowalski C, Becker BF, Gerlach E: Retention of leucocytes in reperfused, isolated hearts does not cause haemodynamically relevant permanent capillary plugging. Pflugers Arch 1997, 433: 713-720. 10.1007/s004240050336CrossRefPubMed
13.
go back to reference Chappell D, Jacob M, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx. Biol Chem 2008, 389: 79-82.CrossRefPubMed Chappell D, Jacob M, Rehm M, Stoeckelhuber M, Welsch U, Conzen P, Becker BF: Heparinase selectively sheds heparan sulphate from the endothelial glycocalyx. Biol Chem 2008, 389: 79-82.CrossRefPubMed
14.
go back to reference Zausig YA, Zink W, Keil M, Sinner B, Barwing J, Wiese CH, Graf BM: Lipid emulsion improves recovery from bupivacaine-induced cardiac arrest, but not from ropivacaine- or mepivacaine-induced cardiac arrest. Anesth Analg 2009, 109: 1323-1326. 10.1213/ane.0b013e3181af7fb3CrossRefPubMed Zausig YA, Zink W, Keil M, Sinner B, Barwing J, Wiese CH, Graf BM: Lipid emulsion improves recovery from bupivacaine-induced cardiac arrest, but not from ropivacaine- or mepivacaine-induced cardiac arrest. Anesth Analg 2009, 109: 1323-1326. 10.1213/ane.0b013e3181af7fb3CrossRefPubMed
15.
go back to reference Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39: 175-191. 10.3758/BF03193146CrossRefPubMed Faul F, Erdfelder E, Lang AG, Buchner A: G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39: 175-191. 10.3758/BF03193146CrossRefPubMed
16.
go back to reference Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA: Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012, 255: 821-829. 10.1097/SLA.0b013e31825074f5CrossRefPubMed Shaw AD, Bagshaw SM, Goldstein SL, Scherer LA, Duan M, Schermer CR, Kellum JA: Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012, 255: 821-829. 10.1097/SLA.0b013e31825074f5CrossRefPubMed
17.
go back to reference Orchard CH, Kentish JC: Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 1990, 258: C967-C981.PubMed Orchard CH, Kentish JC: Effects of changes of pH on the contractile function of cardiac muscle. Am J Physiol 1990, 258: C967-C981.PubMed
18.
go back to reference Fabiato A, Fabiato F: Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles. J Physiol 1978, 276: 233-255.PubMedCentralCrossRefPubMed Fabiato A, Fabiato F: Effects of pH on the myofilaments and the sarcoplasmic reticulum of skinned cells from cardiace and skeletal muscles. J Physiol 1978, 276: 233-255.PubMedCentralCrossRefPubMed
19.
go back to reference Zhou HZ, Malhotra D, Shapiro JI: Contractile dysfunction during metabolic acidosis: role of impaired energy metabolism. Am J Physiol 1991, 261: H1481-H1486.PubMed Zhou HZ, Malhotra D, Shapiro JI: Contractile dysfunction during metabolic acidosis: role of impaired energy metabolism. Am J Physiol 1991, 261: H1481-H1486.PubMed
20.
go back to reference Coles JA Jr, Sigg DC, Iaizzo PA: The potential benefits of 1.5% hetastarch as a cardioplegia additive. Biochem Pharmacol 2005, 69: 1553-1558. 10.1016/j.bcp.2005.03.010CrossRefPubMed Coles JA Jr, Sigg DC, Iaizzo PA: The potential benefits of 1.5% hetastarch as a cardioplegia additive. Biochem Pharmacol 2005, 69: 1553-1558. 10.1016/j.bcp.2005.03.010CrossRefPubMed
21.
go back to reference Dagtekin O, Klisa MA, Gerbershagen HJ, Marcus H, Krep H, Teschendorf P, Fischer JH: Effects of hydroxyethyl starch, gelatin and dextran on endothelium-derived relaxation in porcine coronary arteries. Pharmacology 2010, 86: 267-272. 10.1159/000320955CrossRefPubMed Dagtekin O, Klisa MA, Gerbershagen HJ, Marcus H, Krep H, Teschendorf P, Fischer JH: Effects of hydroxyethyl starch, gelatin and dextran on endothelium-derived relaxation in porcine coronary arteries. Pharmacology 2010, 86: 267-272. 10.1159/000320955CrossRefPubMed
22.
go back to reference Sutherland FJ, Hearse DJ: The isolated blood and perfusion fluid perfused heart. Pharmacol Res 2000, 41: 613-627. 10.1006/phrs.1999.0653CrossRefPubMed Sutherland FJ, Hearse DJ: The isolated blood and perfusion fluid perfused heart. Pharmacol Res 2000, 41: 613-627. 10.1006/phrs.1999.0653CrossRefPubMed
23.
go back to reference Koller A, Sun D, Kaley G: Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 1993, 72: 1276-1284. 10.1161/01.RES.72.6.1276CrossRefPubMed Koller A, Sun D, Kaley G: Role of shear stress and endothelial prostaglandins in flow- and viscosity-induced dilation of arterioles in vitro. Circ Res 1993, 72: 1276-1284. 10.1161/01.RES.72.6.1276CrossRefPubMed
24.
go back to reference Gregg DE: Relationship between coronary flow and metabolic changes. Cardiology 1971, 56: 291-301. 10.1159/000169373CrossRefPubMed Gregg DE: Relationship between coronary flow and metabolic changes. Cardiology 1971, 56: 291-301. 10.1159/000169373CrossRefPubMed
25.
go back to reference Podesser BK, Hallstrom S, Schima H, Huber L, Weisser J, Kroner A, Furst W, Wolner E: The erythrocyte-perfused "working heart" model: hemodynamic and metabolic performance in comparison to crystalloid perfused hearts. J Pharmacol Toxicol Methods 1999, 41: 9-15. 10.1016/S1056-8719(99)00018-0CrossRefPubMed Podesser BK, Hallstrom S, Schima H, Huber L, Weisser J, Kroner A, Furst W, Wolner E: The erythrocyte-perfused "working heart" model: hemodynamic and metabolic performance in comparison to crystalloid perfused hearts. J Pharmacol Toxicol Methods 1999, 41: 9-15. 10.1016/S1056-8719(99)00018-0CrossRefPubMed
Metadata
Title
The impact of crystalloidal and colloidal infusion preparations on coronary vascular integrity, interstitial oedema and cardiac performance in isolated hearts
Authors
York A Zausig
Daniel Chappell
Bernhard F Becker
Daniel Potschka
Hendrik Busse
Kathrin Nixdorf
Diane Bitzinger
Barbara Jacob
Matthias Jacob
Publication date
01-10-2013
Publisher
BioMed Central
Published in
Critical Care / Issue 5/2013
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc12898

Other articles of this Issue 5/2013

Critical Care 5/2013 Go to the issue